Akamatsu, H., Katakami, N., Okamoto, I., Kato, T., Kim, Y. H., Imamura, F., . . . Hida, T. (2018). Osimertinib in Japanese patients with EGFR T790M mutation‐positive advanced non‐small‐cell lung cancer: AURA3 trial. Cancer Sci.
Citação norma ChicagoAkamatsu, Hiroaki, et al. "Osimertinib in Japanese Patients With EGFR T790M Mutation‐positive Advanced Non‐small‐cell Lung Cancer: AURA3 Trial." Cancer Sci 2018.
Citação norma MLAAkamatsu, Hiroaki, et al. "Osimertinib in Japanese Patients With EGFR T790M Mutation‐positive Advanced Non‐small‐cell Lung Cancer: AURA3 Trial." Cancer Sci 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.